ENDRA Life Sciences (NDRA)

Overall impact
B (70)

Commentary

ENDRA Life Sciences is a strong overall performer. With a 'B' rating of 70.3 for overall impact (83rd percentile compared to all companies), ENDRA Life Sciences ranks 51st out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 47 others, and ahead of Hologic, Avinger, Second Sight Medical Products and 101 others. On top material causes for ENDRA Life Sciences's industry (Healthcare Equipment), ENDRA Life Sciences performs well in Child and Maternal Health (80.4 score), Free, Secure Flow of Information (89.7), Technology Innovation (95.7) and 2 other causes where it received an 'A' score and performs poorly in Sanitation Access (32.0 score).
Impact
Cause NDRA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2007
Employees
9
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Mi, United States
Share classes
NDRA
Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses a pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images. This technology is used in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Material causes
Ethos considers the following causes material for ENDRA Life Sciences, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.